Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy.
Oncol Lett
; 19(1): 239-246, 2020 Jan.
Article
in En
| MEDLINE
| ID: mdl-31897135
Full text:
1
Database:
MEDLINE
Type of study:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Year:
2020
Type:
Article